1 April 2024 in Cardiovascular Therapy and Prevention
Создание руководства поддержано Советом по терапевтическим наукам отделения клинической медицины Российской академии наук.
1 March 2007 in Bulletin of Experimental Biology and Medicine
2 August 2007 in International Journal Of Impotence Research
This study was designed to investigate whether angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with erectile dysfunction (ED) in Russian men with metabolic syndrome (MS). A total of 331 men with MS were studied. All patients underwent complex evaluation including the International Index of Erectile Function (IIEF) questionnaire. The ACE I/D polymorphism was determined by polymerase chain reaction. Overall, 182 men (55.0%) had ED according to the IIEF erectile function domain score. In the ED group, the prevalence of DD genotype was found to be significantly higher compared to the non-ED group (P<0.001). In both groups, patients with DD genotype were significantly younger than patients with other genotypes (P<0.001). In addition, in the ED group, the disease affected patients with DD genotype at a significantly younger age (P<0.001). Obtained results give evidence to support the finding that the D allele is a risk factor for the micro- and macrovascular diseases.
2 February 2023 in Russian Journal of Preventive Medicine
Coronary heart disease remains a leading cause of death in adults, accounting for 16% of all deaths worldwide. Atherosclerosis and related complications have a significant share in the structure of cardiovascular diseases. Most adults have a combination of risk factors of varying severity that influence the risk of cardiovascular disease (CVD) and its complications, so total vascular risk estimation is recommended. Although traditional risk factors play an essential role in the development of CVDs, there are significant differences in atherosclerosis severity among patients. Therefore, noninvasive atherosclerotic imaging techniques are still relevant to improve CVD risk assessment. Preclinical vascular lesions were evaluated using the following methods: measurement of coronary calcium, the thickness of the intima-media complex, ankle-brachial index, and pulse wave velocity. Preclinical atherosclerotic vascular lesions were reported to be a predictor of complications. Noninvasive imaging techniques estimate the severity and clinical consequences of atherosclerotic vascular lesions. However, more research is needed to clarify the role of different methods for detecting subclinical atherosclerosis to improve the accuracy of cardiovascular risk assessment.
14 May 2021 in Cardiovascular Therapy and Prevention
On February 25, 2021, an expert round table was held, which considered the problem of interdisciplinary discussion of a coronavirus disease 2019 (COVID-19) and the development of joint actions for management of patients with chronic noncommunicable diseases during a pandemic.
19 February 2024 in Russian Journal of Cardiology
In 2023, the American Heart Association for the first time formally defined cardiovascular-kidney-metabolic (CKM) syndrome as a systemic disease characterized by pathophysiological interactions between metabolic risk factors, chronic kidney disease (CKD), and cardiovascular system, leading to multiple organ dysfunction and a common adverse cardiovascular outcomes. Data are presented based on the pathophysiological mechanisms and clinical manifestations that made it possible to define this syndrome through the interaction between metabolic risk factors, CKD and the cardiovascular system, leading to multiple organ dysfunction and a high level of adverse cardiovascular outcomes. A classification of this syndrome into stages has been determined, for each of which approaches to the diagnosis and management of patients have been defined. CKM syndrome reflects the influence of multisystem pathophysiological relationships embedded in a multi-level socially and clinically determined community of manifestations, the fusion of which specifies clinical outcomes.